Literature DB >> 19521743

Diffuse chronic leptomeningitis with seropositive rheumatoid arthritis: report of a case successfully treated as rheumatoid leptomeningitis.

Kota Shimada1, Toshihiro Matsui, Misato Kawakami, Hiromi Hayakawa, Hidekazu Futami, Kazuya Michishita, Hirokazu Takaoka, Tatsuoh Ikenaka, Akiko Komiya, Hisanori Nakayama, Futoshi Hagiwara, Shoji Sugii, Hiroshi Furukawa, Yoshinori Ozawa, Shigeto Tohma.   

Abstract

A case of biopsy-confirmed chronic leptomeningitis complicating rheumatoid arthritis in a 53-year old female is reported. Her symptoms included weight loss, severe depression, and pyrexia. Magnetic resonance imaging was useful in diagnosis. Intravenous methylprednisolone was prescribed (1 g/day for 3 days), followed by prednisolone (initial dose of 30 mg daily), and this treatment was effective. Her IgG-index, serum levels of soluble interleukin-2 receptor and ferritin, and cerebrospinal level of interleukin-6 paralleled her clinical course.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521743     DOI: 10.1007/s10165-009-0186-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  10 in total

Review 1.  Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.

Authors:  Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima
Journal:  Clin Rheumatol       Date:  2020-04-30       Impact factor: 2.980

2.  Parkinsonism as an initial manifestation of rheumatoid meningitis.

Authors:  Yuka Hayashi; Michito Namekawa; Keisuke Ohtani; Eiju Watanabe; Imaharu Nakano
Journal:  Neurol Sci       Date:  2014-03-01       Impact factor: 3.307

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Rheumatoid meningitis presenting with stroke-like episodes.

Authors:  Pascale Bourgeois; Jean Rivest; Christian Bocti
Journal:  Neurology       Date:  2014-03-19       Impact factor: 9.910

5.  Rheumatoid meningitis.

Authors:  María J Servioli; Chandril Chugh; John M Lee; José Biller
Journal:  Front Neurol       Date:  2011-12-26       Impact factor: 4.003

6.  T-type Ca²⁺ channels regulate the exit of cardiac myocytes from the cell cycle after birth.

Authors:  Fang Wang; Hui Gao; Hajime Kubo; Xiaoxuan Fan; Hongyu Zhang; Remus Berretta; Xiongwen Chen; Thomas Sharp; Timothy Starosta; Catherine Makarewich; Ying Li; Jeffrey D Molkentin; Steven R Houser
Journal:  J Mol Cell Cardiol       Date:  2013-06-04       Impact factor: 5.000

7.  Leptomeningeal inflammation in rheumatoid arthritis.

Authors:  Simona Lattanzi; Claudia Cagnetti; Paolo Di Bella; Marina Scarpelli; Mauro Silvestrini; Leandro Provinciali
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-11-20

8.  Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis.

Authors:  Tomoya Shibahara; Tomonaga Matsushita; Ryu Matsuo; Yoshihisa Fukushima; Kenji Fukuda; Hiroshi Sugimori; Masahiro Kamouchi; Takanari Kitazono; Tetsuro Ago
Journal:  Case Rep Neurol       Date:  2016-07-20

Review 9.  Rheumatoid meningitis: A case report and review of the literature.

Authors:  Zhaoyi Qin; June Kim; Damian Valencia; Lames Hamoodi; Jenna Neltner; Travis Sizemore; Robert Lightfoot
Journal:  Neurol Clin Pract       Date:  2020-02

10.  Importance of Contrast-Enhanced Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging in Various Intracranial Pathologic Conditions.

Authors:  Eun Kyoung Lee; Eun Ja Lee; Sungwon Kim; Yong Seok Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.